Leading AI with Purpose: From Vision to Measurable Value in Healthcare
Artificial intelligence is no longer a distant promise for healthcare. From accelerating drug discovery to improving clinical decision-making and optimizing healthcare systems, AI is beginning to reshape how care is delivered and how innovation reaches patients. However, much of AI’s full potential remains untapped, and realizing it requires thoughtful and strategic collaboration to deliver meaningful benefits for patients.
This was the central theme of Arcera Life Sciences’ Catalyst Forum: “Collaborating to Turn AI Vision into Value,” held in Abu Dhabi on February 3, 2026. Bringing together leaders from healthcare, academia, government, and technology, the forum explored a critical shift: moving beyond AI pilots toward scalable, measurable impact.
From Vision to Healthcare Outcomes
Opening the forum, Arcera CEO Isabel Afonso shared a powerful principle with participants:
AI provides great tools, but leadership determines when those tools create real impact.
She reflected on the recent J.P. Morgan Healthcare Conference, where AI dominated nearly every discussion. Yet, not all use cases demonstrated clear value. The strongest examples were those built around a clearly defined healthcare problem and embedded directly into daily operations.
She outlined three guiding principles for responsible AI leadership:
- Govern with purpose: balance trust, safety, and speed
- Link every AI initiative to a clear healthcare outcome
- Ensure solutions are embedded into operations, not isolated experiments
The Scaling Challenge: From Pilots to Systems
According to McKinsey1, 82% of organizations are using AI and many have begun to use AI agents. But most of that is in pilots. Only 31% are scaling. The gap between experimentation and implementation reflects a deeper challenge: AI transformation is not primarily a technology problem. It is an organizational one.
Research presented during the forum revealed that many organizations feel pressured by their boards and leadership to “use AI.” While ambition is positive, KPI-driven adoption without a clear problem statement can dilute value.
As Yousef Al-Barkawie, Deloitte’s Partner in the Middle East, noted:
We are still treating AI as a technology problem, when in reality it is an organizational change problem.
AI transformation is not about computing power alone. It is about redesigning how organizations work. True value emerges when companies rethink not just their computing infrastructure, but also their operating models and data strategies.
Leading organizations are:
- Strengthening change management
- Investing in workforce capability
- Building enriched data ecosystems through partnerships
From Efficiency Gains to Clinical Breakthroughs
The forum spotlighted real-world examples where AI is already delivering measurable outcomes.
In the UK, 30,000 NHS workers using AI copilots saved an average of 43 minutes per day during the pilot phase. A full rollout could save up to 400,000 staff hours per month, millions annually, enabling staff to focus more effectively on frontlinecare. 2
In the United States, Stanford Medicine clinicians use multiple AI agents to synthesize multimodal patient data before multidisciplinary review meetings. Previously, clinicians spent a considerable amount of their limited time reviewing charts.Now, with AI-generated summaries available upfront, they can focus on decision-making rather than navigating data, improving consistency and care quality while maintaining human oversight. 3
These examples illustrate a critical point: AI creates value when it is embedded in the workflow, not layered on top of it.
The Rise of Agentic AI and Workforce Readiness
The shift from chatbots to “agentic AI” systems capable of autonomous task execution is already reshaping healthcare. Yet access and familiarity remain uneven.
Healthcare professionals will play a pivotal role in shaping how these systems are adopted and trusted.
Integration, not experimentation alone, will determine impact. But scaling requires:
- Workforce training
- Cultural safety for experimentation
- Clear evaluation frameworks
- Transparent governance models
Without these foundations, even powerful systems risk remaining confined to proof-of-concept.
Trust, Transparency, and the Value Exchange
Healthcare AI depends on data, and data depends on trust.
Panel discussions highlighted a growing generational divide. Younger populations may be more comfortable sharing data, but across demographics the same fundamental question remains: “What value do I receive in return?”
Transparency around how systems are built, how data is used, and how decisions are made is essential. Clinicians need explainable tools. Patients need clarity. Institutions need governance frameworks that protect privacy while enablinginnovation.
Responsible AI is not only about compliance. It is about earning and sustaining trust.
Why Abu Dhabi
Throughout the forum, speakers emphasized the unique position of the UAE for responsible AI scaling:
- Long-term national AI strategy
- Coordinated public–private collaboration
- Integrated healthcare and academic institutions
- Regulatory ambition aligned with innovation
In such an ecosystem, experimentation can move more quickly toward structured implementation.
Leadership Choices That Matter
Amit Batra, Chief AI & Health Transformation Officer, EMEA, Microsoft, said that AI investment is rising rapidly, with many organizations significantly increasing the share of their IT budgets dedicated to AI initiatives over the past three years. However, investment alone does not guarantee transformation and value creation.
Leaders must:
- Define precise problem statements
- Align incentives
- Establish AI Centers of Excellence
- Prioritize high-impact use cases
- Stay focused long enough to capture value
As Isabel Afonso concluded in her closing remarks:
Everything begins with one question: What is the problem we are trying to solve? Define the outcome, then work backwards.
In healthcare, purpose is clear: enabling longer, healthier lives. AI becomes transformative only when aligned with that mission.
From Catalyst to Commitment
The Catalyst Forum marked the beginning of the next phase of Arcera’s innovation journey. It also reaffirmed a shared conviction: turning AI vision to measurable value requires collaboration across industry, academia, regulators, and technology partners. It requires shared responsibility and shared benefit.
Arcera has already begun to expand its digital and AI capabilities by further digitizing core operations and commercial functions, enhancing data-driven workflows, and developing the organizational capabilities required to scale AI responsibly. These initiatives aim to strengthen collaboration with healthcare institutions, academic partners, and technology leaders while improving engagement with customers and enabling faster and more informed decision-making across its operations.
Next, Arcera will work with ecosystem partners to translate insights from the forum into structured initiatives focused on responsible AI deployment in life sciences. This includes advancing governance frameworks that support transparent and accountable AI use, while emphasizing practical use cases in which AI can improve decision-making, accelerate innovation, and strengthen healthcare outcomes.
By combining ecosystem collaboration with internal capability building, Arcera aims to move beyond experimentation toward sustainable, scalable impact.
AI will not transform healthcare on its own. Real transformation happens when technology, leadership, and purpose come together to solve meaningful problems for patients and healthcare systems.
Insights and perspectives from participants
1 Source: https://www.mckinsey.com/capabilities/quantumblack/our-insights/the-state-of-ai
2 Source: https://www.gov.uk/government/news/major-nhs-ai-trial-delivers-unprecedented-time-and-cost-savings
3 Source: https://www.microsoft.com/en-us/industry/blog/healthcare/2025/05/19/developing-next-generation-cancer-care-management-with-multi-agent-orchestration/